China's Innovent says its GLP-1 works better than Novo's semaglutide in diabetes study

reuters.com/business/healthcare-pharmaceuticals/chinas-innovent-says-its-glp-1-works-better-than-novos-semaglutide-diabetes-2025-10-27

This story appeared on reuters.com, 2025-10-27 04:37:42.164000.
The Entire Business World on a Single Page. Free to Use →